67-20-9
67-20-9
Chemical Structure
Nitrofurantoin
- CAS No.: 67-20-9
- Formula:C8H6N4O5
- Molecular Weight:238.16
IUPAC Name: (E)-1-(((5-nitrofuran-2-yl)methylene)amino)imidazolidine-2,4-dione
InChIKey: NXFQHRVNIOXGAQ-YCRREMRBSA-N
SMILES: O=C1NC(CN1/N=C/C2=CC=C([N+]([O-])=O)O2)=O
Biological Activity: Nitrofurantoin is a potent and orally active broad-spectrum beta-lactamase antimicrobial agent. Nitrofurantoin acts as an antibiotic and can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nitrofurantoin | 99.71% | Nitrofurantoin is a potent and orally active broad-spectrum beta-lactamase antimicrobial agent. Nitrofurantoin acts as an antibiotic and can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nitrofurantoin (Standard) | 99.74% | Nitrofurantoin (Standard) is the analytical standard of Nitrofurantoin. This product is intended for research and analytical applications. Nitrofurantoin is a potent and orally active broad-spectrum beta-lactamase antimicrobial agent. Nitrofurantoin acts as an antibiotic and can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nitrofurantoin-13C3 | Nitrofurantoin-13C3 is the 13C labeled Nitrofurantoin (HY-A0090). Nitrofurantoin is a potent and orally active broad-spectrum beta-lactamase antimicrobial agent. Nitrofurantoin acts as an antibiotic and can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nifursemizone | 98.72% | Nifursemizone is an antiprotozoal agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dantrolene | 99.93% | Dantrolene is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 μM and an IC50 of 52.3 μM. Dantrolene is also a calcium channel protein inhibitor. Dantrolene inhibits the release of Ca2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dantrolene-13C3 | 99.0% | Dantrolene-13C3 is the 13C3 labeled Dantrolene. Dantrolene (F368), a muscle relaxant, non-competitively inhibits human erythrocyte glutathione reductase. Ki and IC50 values are 111.6 μM and 52.3 μM, respectively. Dantrolene is a ryanodine receptor antagonist and Ca2+ signaling stabilizer. Dantrolene can be used for the research of muscle spasticity, malignant hyperthermia, Huntington's disease and other neuroleptic malignant syndrome. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nifurtoinol | Nifurtoinol is a nitrofuran-derivative antibiotic with antibacterial effects. Nifurtoinol can be used for the research of urinary tract infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-NP-AHD (Standard) | ≥98% | 2-NP-AHD (Standard) is the analytical standard of 2-NP-AHD. This product is intended for research and analytical applications. 2-NP-AHD is a 2-nitrophenyl derivative of AHD (a metabolite of nitrofurans type of antibiotics), can be used as indicator of the illegal usage of nitrofuran agents. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-NP-AHD-13C3 | 2-NP-AHD-13C3 is the 13C labled 2-NP-AHD (HY-136457). 2-NP-AHD is a 2-nitrophenyl derivative of AHD (a metabolite of nitrofurans type of antibiotics), can be used as indicator of the illegal usage of nitrofuran agents. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Furagin | 99.84% | Furagin (Furazidine), an analogue of Nitrofurantoin (HY-A0090), is an antibiotic with antibacterial activity against ESKAPE pathogens with MIC values of 0-32 µg/mL. Furagin inhibits human Carbonic anhydrases . Furagin is promising for research of cancer and urinary tract infections (UTIs). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nitrofurantoin sodium | 99.73% | Nitrofurantoin sodium is a potent and orally active antibacterial agent. Nitrofurantoin sodium acts as an antibiotic. Nitrofurantoin sodium can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Furazolidone | 99.92% | Furazolidone is a monoamine oxidase (MAO) inhibitor with antiproliferative, apoptosis-inducing and differentiation-promoting activities. Furazolidone may inhibit leukemia fusion protein-mediated bone marrow transformation by upregulating the stability of the tumor suppressor protein p53. Furazolidone exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines and can be used for anti-AML research |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
